Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 93

2.

Immunohistochemical evidence of loss of PTEN expression in primary ductal adenocarcinomas of the breast.

Perren A, Weng LP, Boag AH, Ziebold U, Thakore K, Dahia PL, Komminoth P, Lees JA, Mulligan LM, Mutter GL, Eng C.

Am J Pathol. 1999 Oct;155(4):1253-60.

3.

Mutations in the BRCA1-associated RING domain (BARD1) gene in primary breast, ovarian and uterine cancers.

Thai TH, Du F, Tsan JT, Jin Y, Phung A, Spillman MA, Massa HF, Muller CY, Ashfaq R, Mathis JM, Miller DS, Trask BJ, Baer R, Bowcock AM.

Hum Mol Genet. 1998 Feb;7(2):195-202.

PMID:
9425226
4.

[Loss of heterozygosity of tumor suppressor genes at chromosome 3p in transitional cell carcinoma of urinary bladder].

Xiao Z, Zhang J, Zheng S, Li C, He Z, Cheng S, Gao Y.

Zhonghua Yi Xue Za Zhi. 2002 Oct 25;82(20):1375-7. Chinese.

PMID:
12509916
5.

p27/Kip1 mutation found in breast cancer.

Spirin KS, Simpson JF, Takeuchi S, Kawamata N, Miller CW, Koeffler HP.

Cancer Res. 1996 May 15;56(10):2400-4.

6.
7.

Mutation profile of the p53, fhit, p16INK4a/p19ARF and H-ras genes in Indian breast carcinomas.

Kannan K, Krishnamurthy J, Feng J, Nakajima T, Tsuchida N, Shanmugam G.

Int J Oncol. 2000 Nov;17(5):1031-5.

PMID:
11029509
8.

p53 mutations in mammary ductal carcinoma in situ but not in epithelial hyperplasias.

Done SJ, Arneson NC, Ozçelik H, Redston M, Andrulis IL.

Cancer Res. 1998 Feb 15;58(4):785-9.

9.

Molecular pathology of primary and metastatic ductal pancreatic lesions: analyses of mutations and expression of the p53, mdm-2, and p21/WAF-1 genes in sporadic and familial lesions.

Ruggeri BA, Huang L, Berger D, Chang H, Klein-Szanto AJ, Goodrow T, Wood M, Obara T, Heath CW, Lynch H.

Cancer. 1997 Feb 15;79(4):700-16.

PMID:
9024708
10.

Novel somatic mutations in the BRCA1 gene in sporadic breast tumors.

Janatova M, Zikan M, Dundr P, Matous B, Pohlreich P.

Hum Mutat. 2005 Mar;25(3):319.

PMID:
15712267
11.

Allele-specific loss of heterozygosity at the DAL-1/4.1B (EPB41L3) tumor-suppressor gene locus in the absence of mutation.

Kittiniyom K, Mastronardi M, Roemer M, Wells WA, Greenberg ER, Titus-Ernstoff L, Newsham IF.

Genes Chromosomes Cancer. 2004 Jul;40(3):190-203.

PMID:
15138999
13.

Mutation analysis of the CHK2 gene in breast carcinoma and other cancers.

Ingvarsson S, Sigbjornsdottir BI, Huiping C, Hafsteinsdottir SH, Ragnarsson G, Barkardottir RB, Arason A, Egilsson V, Bergthorsson JT.

Breast Cancer Res. 2002;4(3):R4. Epub 2002 Mar 20.

14.

ATBF1 and NQO1 as candidate targets for allelic loss at chromosome arm 16q in breast cancer: absence of somatic ATBF1 mutations and no role for the C609T NQO1 polymorphism.

Cleton-Jansen AM, van Eijk R, Lombaerts M, Schmidt MK, Van't Veer LJ, Philippo K, Zimmerman RM, Peterse JL, Smit VT, van Wezel T, Cornelisse CJ.

BMC Cancer. 2008 Apr 16;8:105. doi: 10.1186/1471-2407-8-105.

15.

Two identical triplet sisters carrying a germline BRCA1 gene mutation acquire very similar breast cancer somatic mutations at multiple other sites throughout the genome.

Wistuba II, Tomlinson GE, Behrens C, Virmani A, Geradts J, Blum JL, Minna JD, Gazdar AF.

Genes Chromosomes Cancer. 2000 Aug;28(4):359-69.

PMID:
10862044
16.
17.

Sequence-ready contig for the 1.4-cM ductal carcinoma in situ loss of heterozygosity region on chromosome 8p22-p23.

Wang JC, Radford DM, Holt MS, Helms C, Goate A, Brandt W, Parik M, Phillips NJ, DeSchryver K, Schuh ME, Fair KL, Ritter JH, Marshall P, Donis-Keller H.

Genomics. 1999 Aug 15;60(1):1-11.

PMID:
10458905
18.

[Microsatellite instability and allele-specific chromosome 3p deletion in breast cancer and precancerous lesions].

Fu Q, Yao GY, Tang XL, Chen LR, Zheng ZX.

Zhonghua Zhong Liu Za Zhi. 2007 Jan;29(1):34-40. Chinese.

PMID:
17575691
19.

Loss of heterozygosity of BRCA1, BRCA2 and ATM genes in sporadic invasive ductal breast carcinoma.

Rio PG, Pernin D, Bay JO, Albuisson E, Kwiatkowski F, De Latour M, Bernard-Gallon DJ, Bignon YJ.

Int J Oncol. 1998 Oct;13(4):849-53.

PMID:
9735416
20.

p53, Ki-ras, and DNA ploidy in human pancreatic ductal adenocarcinomas.

Weyrer K, Feichtinger H, Haun M, Weiss G, Ofner D, Weger AR, Umlauft F, Grünewald K.

Lab Invest. 1996 Jan;74(1):279-89.

PMID:
8569192

Supplemental Content

Support Center